Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients
Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients.
Contact Information
Boston, MAPhone: 617-726-2707
Boston, MAPhone: 617-726-5050
Clinical Interests:
Treats:
Languages:
Mass General Primary Care Urgent Access Center
55 Fruit St.
Wang Ambulatory Care Center
Suite 108
Boston, MA 02114
Phone: 617-726-2707
Mass General Renal Associates
165 Cambridge Street
Suite 302
Boston, MA 02114
Phone: 617-726-5050
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients.
The Severe Immunotherapy Complications Service at Mass General was created to address the urgent need to understand how and why toxicities occur, in order to develop new therapies that will allow patients to safely stay on their lifesaving immunotherapy regimens.
In this interview, Kerry Reynolds, MD chats with Meghan Sise, MD, director of onconephrology at Mass General Hospital, to learn more about how immune checkpoint inhibitor (ICI) therapy affects kidney function.
As scientists learn more about COVID-19, it has become clear that the virus especially impacts those with existing medical conditions, such as kidney disease.
Mass General study demonstrates that kidneys infected with hepatitis C can be safely transplanted into healthy recipients.
The Severe Immunotherapy Complications Service at Mass General was created to address the urgent need to understand how and why toxicities occur, in order to develop new therapies that will allow patients to safely stay on their lifesaving immunotherapy regimens.
In this interview, Kerry Reynolds, MD chats with Meghan Sise, MD, director of onconephrology at Mass General Hospital, to learn more about how immune checkpoint inhibitor (ICI) therapy affects kidney function.
As scientists learn more about COVID-19, it has become clear that the virus especially impacts those with existing medical conditions, such as kidney disease.
Dr Sise is awesome and she really cares about her patients
Dr. Sise immediately puts me at ease. Her professional and compassionate manner always makes me confident that she is highly knowledgeable about my overall health (in addition to my kidneys).
Yes, my additional comments for Dr. Sise. I think that she's an amazing doctor and she's always extremely caring and she talks to my level where you can understand what your medical conditions are. And I think she's very caring and she has a great side manner. She's been my doctor for quite some time and I hope to continue to see her. Thank you so ... Read More
She is a gem! Kind, attentive, personable a good listener easily shares her knowledge and is helpful with her descriptions and recommendations. Keeps in touch with other members of my team.
caring and knowledgable
Excellent manner. Explained everything clearly and went above and beyond. Very positive experience.
Dr. Sise is amazing and provides the best care!
Her insight and input on my kidney issues is greatly appreciated
She is excellent. Information was provided in an understandable manner and all questions were answered in an understandable way. Her demeanor with patients is top-notch.
Both Dr. Sise and her Fellow were well informed about my medical history. They helped to educate my husband and me about my medical conditions and the medications I am currently taking. Both listened carefully to my comments and questions. I was very pleased with this appointment.